CDC Office of Acquisition Services

The Centers for Disease Control and Prevention Office of Acquisition Services, a sub-agency of the Department of Health and Human Services responsible for procuring scientific equipment, information management services, research support, and specialized labor for CDC's disease surveillance, occupational health, and epidemiological missions, has closed its contract award portfolio to new rollup activity as of April 2020.

The agency's historical contract portfolio spans 42,181 awards since 1950, with a combined potential value of $1.991 billion and $18.66 billion in obligated dollars across 6,171 distinct prime contractors. Activity sharply declined after 2016: the agency issued 1,867 awards in 2015, then 363 in 2016, 41 in 2017, 9 in 2018, and 1 in 2020, with no recorded awards since April 2020. Across the portfolio, 90 percent of awards carried no set-aside designation, 5 percent were small-business set-asides, and 2 percent each were competitive 8(a) and 8(a) sole-source awards, with remaining shares distributed among SDVOSB, HUBZone, and specialized programs. The portfolio is highly fragmented—no concentration figures are reported in the source data, and the 6,171 distinct awardees over the lifetime of the account suggest a dispersed competitive base with no identifiable dominant primes.

Contract opportunity activity, by contrast, remains current and substantial. CDC's Office of Acquisition Services and its subordinate centers—including the National Institute for Occupational Safety and Health (NIOSH), the National Center for Health Statistics (NCHS), the National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), and the National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP)—posted 29 solicitations between mid-September and mid-October 2026. Representative opportunities span equipment procurement (mobile SLAM LiDAR scanning systems for NIOSH mine safety research, acoustic emission testing equipment, quantum cascade lasers, carbon dioxide gas analyzers, laboratory automation systems), software licensing and maintenance (ITASCA numerical modeling suite, Maptek PointStudio geotechnical analysis), services (dose reconstruction under EEOICPA, vital statistics coding, healthcare epidemiology research under the SPEED IDIQ vehicle with partial small-business set-asides), and IT maintenance (CDC STI Treatment Guidelines mobile apps). Most solicitations are pre-solicitations seeking market research responses or firm-fixed-price purchase orders on sole-source or brand-name-only bases; a subset—including the Safety, Prevention, Epidemiology, and Education Development for Health Care and Antimicrobial Resistance (SPEED) IDIQ announced October 8 with due date November 8, 2026—carry small-business set-aside designations by functional domain. Recent amendments to solicitations (such as Mobile SLAM LiDAR Scanning Systems 75D301-26-Q-79246, amended twice in September 2026 to revise technical requirements and confirm unrestricted competition) reflect active refinement of acquisition strategy and engagement with industry during the presolicitation phase.